How will the Clinicians, Patients and Consumers of the Future ensure appropriate use of brain enhancement methods encompassing lifestyle, supplements, brain training, meditation, bio/ neurofeedback, tDCS and more?

By SharpBrains | December 27, 2017

How will the Clin­i­cians, Patients and Con­sumers of the Future ensure appro­pri­ate use of brain enhance­ment meth­ods encom­pass­ing lifestyle, sup­ple­ments, brain train­ing, med­i­ta­tion, bio/ neu­ro­feed­back, tDCS and more? (record­ing requires reg­is­tra­tion; view slid­edeck above or Here) Dr. Eddie Mar­tuc­ci, Co-Founder and CEO of Akili Inter­ac­tive Labs Dr. Anna Wexler, sci­ence writer, film­mak­er and post­doc fel­low at the Depart­ment of Medical…

Read More

Pending FDA review and approval, research findings pave way for Akili’s EVO to become first brain training platform prescribed for ADHD

By SharpBrains | December 12, 2017

Akili Achieves Pri­ma­ry Effi­ca­cy End­point in ADHD Tri­al (MD mag­a­zine): “Boston-based Akili Inter­ac­tive has announced top-line results from the STARS-ADHD piv­otal study of its inves­ti­ga­tion­al dig­i­tal ther­a­peu­tic med­i­cine AKL-T01, in treat­ment of pedi­atric atten­­tion-deficit/hy­per­ac­­tiv­i­­ty dis­or­der (ADHD)…The dig­i­tal med­i­cine, AKL-T01, is a video game for patients to play on tablet devices. It uses the same storytelling…

Read More

5 Facts You Need To Know To Understand, Navigate And Enjoy The Digital Brain Health Revolution

By Alvaro Fernandez | April 12, 2017

— Hun­dreds of com­pa­nies around the globe, now includ­ing Elon Musk’s Neu­ralink and even Face­book,  are research­ing and devel­op­ing new ways to help brain own­ers be smarter, sharp­er, and health­i­er. What explains this flur­ry of activ­i­ty? Where may it be head­ed? To help you under­stand what’s going on, let me high­light five key facts that emerged…

Read More

Witnessing an explosion of consumer-facing neurotechnologies to (potentially) harness lifelong neuroplasticity

By Apoorv Mathur | January 30, 2017

— Last week I shared some key sci­en­tif­ic, tech­no­log­i­cal and invest­ment trends rev­o­lu­tion­iz­ing Brain Health, based on my par­tic­i­pa­tion at the 2016 Sharp­Brains Vir­tu­al Sum­mit, and promised a sec­ond arti­cle more focused on the tech­nol­o­gy side of things. Here it is :-) Just a few weeks after the Sharp­Brains Sum­mit I also attend­ed CES 2017. While I enjoyed the myr­i­ad emerging…

Read More

Akili raises an additional $11.9M; brings Amgen, Merck, Pfizer and Shire to the digital medicine table

By SharpBrains | July 21, 2016

—– Akili Adds Amgen Ven­tures and M Ven­tures* to Series B Financ­ing, Increas­ing Round to $42.4 Mil­lion (press release): “Akili Inter­ac­tive Labs, Inc. (“Akili”), a dig­i­tal med­i­cine com­pa­ny devel­op­ing nov­el, non-phar­­ma­­co­log­i­­cal ther­a­peu­tics and diag­nos­tics for cog­ni­tive dis­or­ders, today announced an $11.9 mil­lion expan­sion of its recent Series B financing. 

Read More